Who isnt a good candidate for weight loss injections
The primary outcome was three major adverse cardiovascular events (MACE) AMI, stroke, and all-cause mortality which showed significantly reduced odds in the GLP-1RA group
Over the long term, hunger levels decrease progressively
also approved for chronic weight management in adults (refer to current MHRA and NICE Technology Appraisal guidance for the applicable indication and eligibility criteria) [4] [7] Orlistat available on NHS prescription and over the counter Naltrexone/bupropion (Mysimba) available in some settings, though NHS commissioning varies by region [10] NICE Technology Appraisals provide eligibility criteria and commissioning guidance for semaglutide and tirzepatide in weight management
Professional Administration: At Sermedspa, B12 injections are administered by skilled professionals in a comfortable and sterile environment
There is no solid evidence that GLP-1 meds cause NAION, and the absolute risk if there even is one is so low it barely registers